SCHEMBL32688186

SCHEMBL32688186

N#Cc1c(SCc2nnn[nH]2)[nH]c(=O)c(C(=O)N2CCCC2)c1-c1cccc(-c2ccccc2)c1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 8/20 0.37
▸ CUL4A Q13619 1/20 0.36
▸ KMT2A Q03164 4/20 0.33
▸ ACMSD Q8TDX5 1/20 0.33
▸ MGLL Q99685 1/20 0.33
▸ HPGD P15428 4/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.32
▸ FASN P49327 1/20 0.32
▸ CXCR2 P25025 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688485 0.88 KMT2A (0.33) HSD11B1CUL4AKMT2AACMSDHPGD
SCHEMBL32688001 0.87 CUL4A (0.49) HSD11B1CUL4AKMT2AACMSDHPGD
SCHEMBL32688370 0.84 POLB (0.41) HSD11B1KMT2AACMSDHPGDMEN1
SCHEMBL32688365 0.83 ALDH1A1 (0.44) KMT2AACMSDHPGDMEN1ALDH1A1
SCHEMBL32688035 0.82 MEN1 (0.41) HSD11B1KMT2AACMSDMEN1POLB
SCHEMBL32688298 0.81 POLB (0.37) HSD11B1KMT2AACMSDHPGDMEN1
SCHEMBL32688401 0.81 POLB (0.37) HSD11B1KMT2AACMSDHPGDMEN1
SCHEMBL32688318 0.80 ALDH1A1 (0.40) KMT2AMGLLHPGDMEN1ALDH1A1
SCHEMBL32688136 0.78 HSD11B1 (0.41) HSD11B1KMT2AACMSDMEN1ALDH1A1
SCHEMBL32688008 0.77 MEN1 (0.42) HSD11B1KMT2AACMSDHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK HSD11B1 61/4885CUL4A 2621/4885KMT2A 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback